Emmaus Life Sciences Stock EBITDA
EMMADelisted Stock | USD 0.13 0.00 0.00% |
Emmaus Life Sciences fundamentals help investors to digest information that contributes to Emmaus Life's financial success or failures. It also enables traders to predict the movement of Emmaus OTC Stock. The fundamental analysis module provides a way to measure Emmaus Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emmaus Life otc stock.
Emmaus |
Emmaus Life Sciences OTC Stock EBITDA Analysis
Emmaus Life's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Emmaus Life EBITDA | (12.76 M) |
Most of Emmaus Life's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emmaus Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Emmaus Life Sciences reported earnings before interest,tax, depreciation and amortization of (12.76 Million). This is 101.45% lower than that of the Pharmaceuticals sector and 112.74% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.33% higher than that of the company.
Emmaus EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emmaus Life's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emmaus Life could also be used in its relative valuation, which is a method of valuing Emmaus Life by comparing valuation metrics of similar companies.Emmaus Life is currently under evaluation in ebitda category among related companies.
Emmaus Fundamentals
Return On Asset | -0.12 | ||||
Profit Margin | (1.14) % | ||||
Operating Margin | (0.65) % | ||||
Current Valuation | 49.41 M | ||||
Shares Outstanding | 49.56 M | ||||
Shares Owned By Insiders | 38.73 % | ||||
Number Of Shares Shorted | 41.22 K | ||||
Price To Earning | (1.60) X | ||||
Price To Sales | 1.06 X | ||||
Revenue | 20.61 M | ||||
Gross Profit | 17.3 M | ||||
EBITDA | (12.76 M) | ||||
Net Income | (15.95 M) | ||||
Cash And Equivalents | 982 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 4.65 M | ||||
Debt To Equity | (0.04) % | ||||
Current Ratio | 0.14 X | ||||
Book Value Per Share | (0.76) X | ||||
Cash Flow From Operations | (1.25 M) | ||||
Short Ratio | 0.48 X | ||||
Earnings Per Share | (0.18) X | ||||
Target Price | 4.0 | ||||
Number Of Employees | 58 | ||||
Beta | 1.97 | ||||
Market Capitalization | 24.28 M | ||||
Total Asset | 56.73 M | ||||
Retained Earnings | (82.78 M) | ||||
Working Capital | 1.95 M | ||||
Current Asset | 9.19 M | ||||
Current Liabilities | 7.25 M | ||||
Z Score | 1.6 | ||||
Net Asset | 56.73 M |
About Emmaus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Emmaus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emmaus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emmaus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Emmaus Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emmaus Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will appreciate offsetting losses from the drop in the long position's value.Moving against Emmaus OTC Stock
0.74 | VCEL | Vericel Corp Ord Financial Report 8th of May 2024 | PairCorr |
0.68 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
0.67 | VERA | Vera Therapeutics Downward Rally | PairCorr |
0.54 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.46 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Emmaus Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emmaus Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emmaus Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emmaus Life Sciences to buy it.
The correlation of Emmaus Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emmaus Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emmaus Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emmaus Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |